Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1980 2
1983 1
1984 1
1985 1
1986 4
1987 4
1988 1
1989 1
1990 4
1991 4
1993 2
1994 2
1995 2
1997 3
1998 3
1999 3
2000 1
2001 4
2002 1
2003 5
2004 9
2005 11
2006 14
2007 14
2008 10
2009 7
2010 5
2011 4
2012 14
2013 11
2014 17
2015 12
2016 13
2017 5
2018 8
2019 2
2020 7
2021 14
2022 9
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells.
Reincke SM, von Wardenburg N, Homeyer MA, Kornau HC, Spagni G, Li LY, Kreye J, Sánchez-Sendín E, Blumenau S, Stappert D, Radbruch H, Hauser AE, Künkele A, Edes I, Schmitz D, Prüss H. Reincke SM, et al. Among authors: edes i. Cell. 2023 Nov 9;186(23):5084-5097.e18. doi: 10.1016/j.cell.2023.10.001. Epub 2023 Nov 1. Cell. 2023. PMID: 37918394
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LMA, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RHG, Toller W, Tritapepe L, Tschöpe C, Wikström G, Lewinski DV, Vrtovec B, Pollesello P. Papp Z, et al. Among authors: edes i. J Cardiovasc Pharmacol. 2020 Jul;76(1):4-22. doi: 10.1097/FJC.0000000000000859. J Cardiovasc Pharmacol. 2020. PMID: 32639325 Free PMC article. Review.
[The role of extracorporeal life support in cardiopulmonary resuscitation].
Kovács E, Németh E, Prigya J, Szvath P, Édes I, Hartyánszky I, Soltész Á, Csikós GR, Fazekas L, Gál J, Becker D, Merkely B, Zima E. Kovács E, et al. Among authors: edes i. Orv Hetil. 2023 Apr 2;164(13):510-514. doi: 10.1556/650.2023.32727. Print 2023 Apr 2. Orv Hetil. 2023. PMID: 36966404 Review. Hungarian.
Renal effects of levosimendan: a consensus report.
Yilmaz MB, Grossini E, Silva Cardoso JC, Édes I, Fedele F, Pollesello P, Kivikko M, Harjola VP, Hasslacher J, Mebazaa A, Morelli A, le Noble J, Oldner A, Oulego Erroz I, Parissis JT, Parkhomenko A, Poelzl G, Rehberg S, Ricksten SE, Rodríguez Fernández LM, Salmenperä M, Singer M, Treskatsch S, Vrtovec B, Wikström G. Yilmaz MB, et al. Among authors: edes i. Cardiovasc Drugs Ther. 2013 Dec;27(6):581-90. doi: 10.1007/s10557-013-6485-6. Cardiovasc Drugs Ther. 2013. PMID: 23929366 Free PMC article. Review.
[Ischaemic heart disease in cancer patients. Questions and problems].
Gulácsi-Bárdos P, Szokol M, Lódi M, Czuriga D, Czuriga I, Édes I, Nagy A, Sármán B. Gulácsi-Bárdos P, et al. Among authors: edes i. Orv Hetil. 2017 Oct;158(43):1691-1697. doi: 10.1556/650.2017.30897. Orv Hetil. 2017. PMID: 29135296 Review. Hungarian.
TCR and CAR Engineering of Primary Human T Cells.
Edes I, Clauss J, Stahn R, Japp AS, Lorenz FKM. Edes I, et al. Methods Mol Biol. 2022;2521:85-93. doi: 10.1007/978-1-0716-2441-8_5. Methods Mol Biol. 2022. PMID: 35732994
229 results